Connective tissue diseases and the heart;Enfermedades del tejido conectivo y corazón

Revista Espanola de Cardiologia

Volumn 51, Issue 3, 1998, Pages 232-242

  Galve, Enrique ^a   Ordi, Josep ^a   Candell, Jaume ^a   Soler, Jordi Soler ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Collagen diseases; Connective tissue diseases; Systemic diseases

Indexed keywords

CONNECTIVE TISSUE DISEASE; HEART DISEASE; HUMAN; PATHOLOGY; REVIEW;

CONNECTIVE TISSUE DISEASES; HEART DISEASES; HUMANS;

EID: 0032016392     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(98)74738-4     Document Type: Article

References (86)

1. Nihoyannopoulos P, Gómez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus: association with raised anticardiolipin antibodies. Circulation 1990; 82: 369-375.
2. Ansari A, Larson PH, Bates HD. Cardiovascular manifestations of systemic lupus erythematosus. Progr Cardiovasc Dis 1985; 6: 421-434.
3. Bahl VK, Vasan RS, Aradhye S, Malaviya AN. Prevalence of cardiac abnormalities early in the course of systemic lupus erythematosus. Am J Cardiol 1991; 68: 1.540-1.541.
4. Bridgen W, Bywaters EGC, Lessof MH, Ross IP. The heart in systemic lupus erythematosus Br Heart J 1960; 22: 1-16.
5. Heijtmancik M, Wright JC, Quint R, Jennings FL. The cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1964; 68: 118-130.
6. Porcel JM, Selva A, Tornos MP, Galve E, Soler-Soler J. Resolution of cardiac tamponade in systemic lupus erythematosus with indomethacin. Chest 1989; 96: 1.193-1.194.
7. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985; 110: 1.257-1.265.
8. Borenstein DG, Fye WB, Arnett FC, Stevens MB. The myocarditis of systemic lupus erythematosus: association with myositis. Ann Intern Med 1978; 89: 619-624.
9. Jolies PR, Tatum JL. SLE myocarditis. Detection by Ga-67 citrate scintigraphy. Clin Nucl Med 1996; 21: 284-286.
10. Winslow TM, Ossipov MA, Fazio GP, Foster E, Simonson JS, Schiller NB. The left ventricle in systemic lupus erythematosus: initial observations and a five-year follow-up in a university medical center population. Am Heart J 1993; 125: 1.117-1.122.
11. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 1975; 58: 243-264.
12. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924; 33: 701-737.
13. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, García del Castillo H, Soler-Soler J. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 1988; 319: 817-823.
14. Cervera R, Font J, Paré C, Azqueta M, Pérez-Villa F, López-Soto A et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992; 51: 156-159.
15. Crozier IG, Li E, Milne M, Nichols G. Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 1990; 65: 1.145-1.148.
16. Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992; 20: 1.127-1.134.
17. Morin AM, Boyer AS, Nataf P, Gandjbakhch I. Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac Cardiovasc Surg 1996; 44: 313-316.
18. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996; 335: 1.424-1.430.
19. Gordon RJ, Weilbaecher D, Davy SM, Safi HJ, Quinones MA, DeFelice CA et al. Valvulitis involving a bioprosthetic valve in a patient with systemic lupus erythematous. J Am Soc Echocardiogr 1996; 9: 104-107.
20. Kalangos A, Panos A, Sezerman O. Mitral valve repair in lupus valvulitis. Report of a case and review of the literature. J Heart Valve Dis 1995; 4: 202-207.
21. Galve E, Ordi J, Candell Riera J, Permanyer Miralda G, Vilardell M, Soler Soler J. Valvular heart disease in systemic lupus erythematosus. N Engl J Med 1989; 320: 739-741.
22. Font J, Cervera R, López Soto A, Pallarés L, Bosch X, Ampurdanés S et al. Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations. Clin Rheumatol 1989; 8: 475-483.
23. Tornos MP, Galve E, Pahissa A. Clinical considerations regarding infective Libman-Sacks endocarditis. Int J Cardiol 1985; 5: 409-412.
24. Asherson RA, Cervera R. Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation 1991; 84: 920-923.
25. Nobrega TP, Klodas E, Breen JF, Liggett SP, Higano ST, Reeder GS. Giant coronary artery aneurysms and myocardial infarction in a patient with systemic lupus erythematosus. Cathet Cardiovasc Diagn 1996; 39: 75-79.
26. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP et al. Connective tissue disease, antibodies to ribonucleoproteins and congenital heart block. N Engl J Med 1983; 309: 209-212
27. Reed BR, Lee LA, Harmon C. Autoantibodies to SS-A/Ro in infants with congenital heart block. J Paediatr 1983; 103: 889-891.
28. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM, Silverman ED. Long-term outcome of mothers of children with complete congenital heart block. Am J Med 1996; 100: 328-332.
29. Lagana B, Tubani L, Maffeo N, Vella C, Makk E, Baratta L et al. Heart rate variability and cardiac autonomic function in systemic lupus erythematosus. Lupus 1996; 5: 49-55.
30. Stein KS, McFarlane IC, Goldberg N, Ginzler EM. Heart rate variability in patients with systemic lupus erythematosus. Lupus 1996; 5: 44-48.
31. Soulier JP, Boffa MC. Avortements à répétition, thromboses et anticoagulant circulant anti-thromboplastine. Nouv Presse Med 1980; 9: 859-864.
32. Bernstein ML, Salusinsky-Sternbah M, Bellefleur M, Essletine DW. Thrombotic and hemorrhagic complications in children with the lupus anticoagulant. Am J Dis Child 1984; 138: 1.132-1.135.
33. Hughes GRV, Harris N, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-489.
34. Much JR, Herbst KD, Rapaport SI. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980; 92: 156-159.
35. Rand JH, Xiao-Xuan W, Andree HAM, Lockwood CJ, Guller S, Scher J et al. Pregnancy loss in the antiphospholipid-antibody syndrome. A possible mechanism. N Engl J Med 1997; 337: 154-160.
36. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RH, Machin SJ, Barquinero et al. The «primary» antiphospholid syndrome. Major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-374.
37. Asherson RA, Harris EN. Anticardiolipin antibodies-clinical associations. Postgrad Med J 1986; 62: 1.081-1.087.
38. Ford PM, Ford SE, Lillicrap DP. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. J Rheumatol 1988; 15: 597-600.
39. Chartash EK, Lans DM, Paget SA, Qamar T, Lockshin MD. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 1989; 86: 407-412.
40. Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 1.541-1.544.
41. Galve E, Ordi J, García H, Barquinero J, Vilardell M, Soler J. Cardiac valvular involvement in primary antiphospholipid syndrome. Circulation 1990; 82 (Supl 3): 397.
42. Galve E, Ordi J, Barquinero J, Evangelista A, Vilardell M, Soler-Soler J. Valvular heart disease in the primery antiphospholipid syndrome. Ann Intern Med 1992; 116: 293-298.
43. Bouillanne O, Millaire A, De Groote P, Puisieux F, Cesbron JY, Jude B et al. Prevalence and clinical significance of antiphospholipid antibodies in heart valve disease: a case-control study. Am Heart J 1996; 132: 790-795.
44. Asherson RA, Cervera R. Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation 1991; 84: 920-923.
45. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996; 93: 1.579-1.587.
46. García Torres R, Amigo MC, De la Rosa A, Morón A, Reyes PA. Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings. Lupus 1996; 5: 56-61.
47. Romero Ferrer B, Galve Basilic E, Ordi Ros J, Pérez Pemán P, Falgá Tirado C, Soler-Soler J. Trombosis coronaria como manifestación del síndrome antifosfolípido. Rev Esp Cardiol 1994; 47: 327-329.
48. Asherson RA, Mackay IR, Harris EN. Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid. Br Heart J 1986; 56: 190-193.
49. Norberg RJ, Ernerudh J, Hamsten A, Unander AM, Arfors L. Phospholipid antibodies in cardiovascular disease. Acta Med Scand 1987; 715: 93-98.
50. Klemp P, Cooper RC, Strauss J, Jordaan ER, Przybojewski JZ, Nel N. Anti-cardiolipin antibodies in ischaemic heart disease. Clin Exp Rheumatol 1988; 74: 254-257.
51. Sletnes KE, Smith P, Abdelnoor M, Arnesen H, Wisloff F. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet 1992; 339: 451-453.
52. Murphy JJ, Leach IH. Findings at necropsy in the heart of a patient with anticardiolipin syndrome. Br Heart J 1989; 62: 61-64.
53. Coudray N, De Zuttere D, Bletry O, Piette JC, Wechsler B, Godeau P et al. M mode and Doppler echocardiographic assessment of left ventricular diastolic function in primary antiphospholipid syndrome. Br Heart J 1995 74: 531-535.
54. Lubbe WF, Asherson RA. Intracardiac thrombus in systemic lupus erythematosus associated with lupus anticoagulant. Arthritis Rheum 1988; 31: 1.453-1.454.
55. Leventhal LJ, Borofsky MA, Bergey PD, Schumacher HR Jr. Antiphospholipid antibody syndrome with right atrial thrombosis mimicking an atrial myxoma. Am J Med 1989; 87: 111-113.
56. Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GRV. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990; 17: 1.292-1.298.
57. Deswal A, Follansbee WP. Cardiac involvement in scleroderma. Rheum Dis Clin North Am 1996; 22: 841-860.
58. Goldman AP, Kotler MN. Heart disease in scleroderma. Am Heart J 1985; 110: 1.043-1.046.
59. Janosik DL, Osbom TG, Moore TL, Shah DG, Kenney RG, Zuckner J. Heart disease in systemic sclerosis. Semin Arthritis Rheum 1989; 19: 191-200.
60. Oram S, Stokes W. The heart in scleroderma. Br Heart J 1961; 23: 243-259.
61. Sackner MA, Heinz ER, Steinberg AJ. The heart in scleroderma. Am J Cardiol 1966; 17: 542-559.
62. McWhorter JE, LeRoy EC. Pericardial disease in scleroderma (systemic sclerosis). Am J Med 1974; 57: 566-575.
63. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation 1976; 53: 483-490.
64. Schwaiblmair M, Behr J, Fruhmann G. Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis. Chest 1996; 110: 1.520-1.525.
65. Murata I, Takenaka K, Yoshinoya S, Kikuchi K, Kiuchi T, Tanigawa T et al. Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients. Chest 1997; 111: 36-43.
66. Candell Riera J, Armadans Gil L, Simeón CP, Castell Conesa J, Fonollosa PLa V, García del Castillo H et al. Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum 1992; 35: 1.356-1.361.
67. Deswal A, Follansbee WP. Cardiac involvement in scleroderma. Rheum Dis Clin North Am 1996; 22: 841-860.
68. Nishioka K, Katayama I, Kondo H, Shinkai H, Ueki H, Tamaki K et al. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). J Dermatol 1996; 23: 677-682.
69. Rodeheffer RJ, Rommer JA, Wigley F, Smith CR. Controlled double blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 1983; 308: 880-883.
70. Geirsson AJ, Danielsen R, Petursson E. Left ventricular myocardial perfusion and function in systemic sclerosis before and after diltiazem treatment. Scand J Rheumatol 1996; 25: 317-320.
71. Lekakis J, Mavrikakis M, Emmanuel M, Prassopoulos V, Papamichael C, Moupoulou D et al. Acute estrogen administration can reverse cold-induced coronary Raynaud's phenomenon in systemic sclerosis. Clin Exp Rheumatol 1996; 14: 421-424.
72. Williamson DJ, Hayward C, Rogers P, Wallman LL, Sturgess AD, Penny R et al. Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension. Circulation 1996; 94: 477-482.
73. Oppenheim H. Zur Dermatomyositis. Berl Klin Wochenschr 1899; 36: 805-807.
74. Denvow CE, Lie JT, Tancredi RG, Bunch TW. Cardiac involvement in polymyositis. A clinicopathologic study of 20 autopsied patients. Arthritis Rheum 1979; 22: 1.088-1.092.
75. Schaumberg HH, Nielsen SL, Yurchak PM. Heart block in polymyositis. N Engl J Med 1971; 284: 480-481.
76. Alpert MA, Goldberg SH, Singsen BH, Durjam JB, Sharp GC, Ahmad M et al. Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation 1983; 68: 1.182-1.193.
77. Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation. Circulation 1973; 48: 1.014-1.027.
78. Stamato T, Laxer RM, De Freitas C, Gow R, Silverman ED, Luy L et al. Prevalence of cardiac manifestations of juvenile ankylosing spondylitis. Am J Cardiol 1995; 75: 744-746.
79. Kawasuji M, Hetzer R, Oelert H, Stauch G, Borst HG. Aortic valve replacement and ascending aorta replacement in ankylosing spondylitis: report of three surgical cases and review of the literature. Thorac Cardiovasc Surg 1982; 30: 310-314.
80. De Almeida FA, Albanesi-Filho FM, De Albuquerque EM, Magalhaes EC, de Menezes ME. El ecocardiograma en la evaluación del compromiso cardiaco en las espondiloartropatías seronegativas. Medicina (Buenos Aires) 1995; 55: 231-236.
81. Holsinger DR, Osmundson PJ, Edwards JE. The heart in periarteritis nodosa. Circulation 1962; 25: 610-618.
82. Schrader ML, Hochman JS, Bulkley BH. The heart in polyarteritis nodosa: a clinicopathologic study. Am Heart J 1985; 109: 1.353-1.359.
83. Fauci AS, Wolf SM. Wegener's granulomatosis: studies in eighteen patients and a review of the literature. Medicine (Baltimore) 1973; 52: 535-561.
84. Melish ME, Hicks RV. Kawasaki syndrome: clinical features, pathophysiology, etiology and therapy. J Rheumatol 1990; 17 (Supl 24): 2-10.
85. Lie JT. Cardiac and pulmonary manifestations of Behçet syndrome. Pathol Res Pract 1988; 183: 347-355.
86. McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 1976, 55: 193-215.